Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.835
+0.145 (5.39%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Cellectis Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Cellectis stock has a consensus rating of "Buy" and an average price target of $7.60. The average 1-year stock price forecast is 168.08% higher than the current stock price, while the lowest is $4.00 (+41.09%) and the highest is $10 (+252.73%).
Price Target: $7.60 (+168.08%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cellectis stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $9 | Buy | Maintains | $9 | +217.46% | Aug 7, 2026 |
| Clear Street | Clear Street | Buy Maintains $9 | Buy | Maintains | $9 | +217.46% | Mar 20, 2026 |
Financial Forecast
Revenue This Year
51.65M
from 79.59M
Decreased by -35.10%
Revenue Next Year
77.15M
from 51.65M
Increased by 49.35%
EPS This Year
-0.86
from -0.61
EPS Next Year
-1.81
from -0.86
EPS and Forward PE are based on non-GAAP adjusted numbers.